We don’t just formulate medicines. We engineer commercially scalable pharmaceutical manufacturing processes.
STEERLife is a specialized CRO/CDMO offering drug development & manufacturing solutions to pharmaceutical manufacturers, marketers and distributors.
Backed by 16+ years of expertise and the engineering legacy of STEER World, we enable scalable, efficient development and manufacturing of complex and high-potency drug products. With a strong focus on Oncology, Anti-Retroviral therapies, and High-barrier drug formulations, STEERLife partners with pharmaceutical companies to deliver end-to-end CRDMO services, supporting product development from early formulation to commercial manufacturing.
At STEER every development programme is engineered for successful technology transfer and commercial manufacturing.
Pharmaceutical CDMOs, manufacturers, and marketers developing complex generics and difficult-to-formulate drugs face these critical challenges.
Highly potent, poorly flowing, heat-sensitive or difficult-to-melt-fuse APIs demand precise continuous processing that conventional batch equipment struggles to deliver consistently.
Oncology, hormonal and other highly potent compounds require contained manufacturing with minimal operator exposure, reduced product handling and robust GMP compliance.
Developing differentiated generic products requires integration of formulation science, process engineering and scalable manufacturing to achieve robust commercial performance.
Complex generics with multiple actives and bioavailability hurdles require integrated expertise bridging advanced formulation science with cutting-edge manufacturing technology.
Conventional solvent-based manufacturing introduces solvent recovery, environmental burden, scale-up complexity and regulatory challenges. STEER enables solvent-free continuous processing for many applications.
R&D formulations translated into manufacturing-ready processes.
Technology transfer support ensuring success at your facility.
Continuous manufacturing systems that maintain formula integrity and consistency.
Compliance-ready scaled solutions for market deployment.
Development Designed for Commercialization Every formulation is engineered with commercial scale-up, technology transfer and regulatory compliance in mind from the very beginning - minimizing redevelopment during commercialization.
Science-driven Problem Solving Our multidisciplinary scientists integrate formulation science, process engineering and regulatory strategy to develop practical, commercially scalable solutions.
Technology Transfer without Surprises Our development philosophy emphasizes process understanding, scalable operating windows and complete technology transfer packages that enable rapid implementation at customer manufacturing sites. Because we believe that technology transfer should be a predictable process - not a second development project.
Continuous Manufacturing Expertise STEER combines advanced formulation science with proprietary continuous manufacturing technologies that deliver superior process control, consistency and scalability.
One Partner throughout the Journey Unlike conventional service providers, STEER combines Pharmaceutical formulation development, Continuous process engineering, Manufacturing technology, Scale-up, Technology transfer & Commercial implementation within a single integrated organization.
Traditional OEMs excel at equipment engineering but lack formulation expertise.
Traditional CDMOs understand formulation development but lack deep equipment knowledge.
STEERLife uniquely combines both with dual expertise.
STEERLife combines formulation expertise with equipment engineering capabilities.
This integrated strength enables efficient development and scalable manufacturing solutions, a unique advantage unseen elsewhere in the global pharmaceutical industry.
STEERLife is part of STEER World, a global leader in materials transformation technology. It leverages continuous manufacturing across pharmaceuticals, nutraceuticals, food, and beverage industries.
The company’s core technologies are Hot Melt Extrusion (HME) and Continuous Granulation (Twin-Screw Granulation), which enable efficient processing of complex and poorly soluble drugs.
It addresses issues like poor drug solubility, complex APIs, and unstable formulations. It also solves challenges in potency control, scalability, and regulatory compliance.
The company uses continuous manufacturing instead of traditional batch processes. This ensures better quality control, scalability, and efficiency in drug production.
STEERLife provides complete technology transfer, enabling partners to manufacture locally while retaining dossier ownership and ensuring compliance at a commercial scale.
© 2026 STEER Engineering Pvt. Ltd. All Rights Reserved.
Changing the Way we Make and Take Medicines.
